278 related articles for article (PubMed ID: 31051027)
1. Atypical Fibroxanthoma.
Chapman LW; Yu SS; Arron ST
Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
[TBL] [Abstract][Full Text] [Related]
2. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
3. Atypical fibroxanthoma/malignant fibrous histiocytoma.
Marcet S
Dermatol Ther; 2008; 21(6):424-7. PubMed ID: 19076618
[TBL] [Abstract][Full Text] [Related]
4. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
5. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
6. Atypical fibroxanthoma management: Recurrence, metastasis and disease-specific death.
Polcz MM; Sebaratnam DF; Fernández-Peñas P
Australas J Dermatol; 2018 Feb; 59(1):10-25. PubMed ID: 28815551
[TBL] [Abstract][Full Text] [Related]
7. Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision.
Tolkachjov SN; Kelley BF; Alahdab F; Erwin PJ; Brewer JD
J Am Acad Dermatol; 2018 Nov; 79(5):929-934.e6. PubMed ID: 29981390
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior.
Carletti M; Nguyen DA; Malouf P; Ingersoll Z; Hosler GA; Weis SE
HCA Healthc J Med; 2022; 3(5):299-304. PubMed ID: 37425251
[TBL] [Abstract][Full Text] [Related]
9. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data.
Ørholt M; Aaberg FL; Abebe K; Walsh S; Roenigk RK; Venzo A; Schmidt G; Klyver H; Jensen DH; Herly M; Vester-Glowinski PV
J Surg Oncol; 2022 Sep; 126(3):555-562. PubMed ID: 35441377
[TBL] [Abstract][Full Text] [Related]
11. Recurrent atypical fibroxanthoma of the cheek.
Skoulas IG; Price M; Andrew JE; Kountakis SE
Am J Otolaryngol; 2001; 22(1):73-5. PubMed ID: 11172219
[TBL] [Abstract][Full Text] [Related]
12. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
Ly H; Selva D; James CL; Huilgol SC
Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
[TBL] [Abstract][Full Text] [Related]
13. Irradiated Skeletal Muscle Cells Mimicking Those of Atypical Fibroxanthoma on Mohs Frozen Sections.
Xiong MY; Kolker S; Bennett RG
Am J Dermatopathol; 2021 May; 43(5):362-364. PubMed ID: 32956095
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
Chen SX; Eichenfield DZ; Orme C; Hinds B
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146
[TBL] [Abstract][Full Text] [Related]
15. Localized cutaneous metastases from an atypical fibroxanthoma.
Giuffrida TJ; Kligora CJ; Goldstein GD
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1561-4. PubMed ID: 15606841
[TBL] [Abstract][Full Text] [Related]
16. Surgical excision margins for fibrohistiocytic tumors, including atypical fibroxanthoma and undifferentiated pleomorphic sarcoma: A probability model based on a systematic review.
Jibbe A; Worley B; Miller CH; Alam M
J Am Acad Dermatol; 2022 Oct; 87(4):833-840. PubMed ID: 34587553
[TBL] [Abstract][Full Text] [Related]
17. [Atypical fibroxanthoma and pleomorphic dermal sarcoma].
Ziemer M; Jäger IM; Dippel E
Hautarzt; 2019 Sep; 70(9):661-669. PubMed ID: 31468069
[TBL] [Abstract][Full Text] [Related]
18. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
19. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma.
Davis JL; Randle HW; Zalla MJ; Roenigk RK; Brodland DG
Dermatol Surg; 1997 Feb; 23(2):105-10. PubMed ID: 9107284
[TBL] [Abstract][Full Text] [Related]
20. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]